Indutrade acquires additional medtech company

Indutrade today signed an agreement to acquire all of the shares in Medexa Diagnostisk Service AB, with annual sales of approximately SEK 25 million.

Medexa specialises in high-end technology for healthcare with a focus on foetal surveillance and ultrasound applications. Customers consist primarily of county councils and private clinics.

Indutrade takes possession of the company today, and it will be part of the Industrial Components business area. The acquisition is expected to have a marginally positive impact on Indutrade’s earnings per share. 

Since 2008, annual sales in Indutrade’s medical technology segment have grown from approximately SEK 60 million to approximately SEK 400 million.

Stockholm, 8 October 2013